pagoclone

DRUG4 trials

Sponsors

Endo Pharmaceuticals, Pharmacology Research Institute

Conditions

Persistent Developmental StutteringPremature EjaculationStuttering

Phase 2

EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

CompletedNCT00216255

Endo PharmaceuticalsPersistent Developmental Stuttering

Start: 2005-04-30End: 2011-07-31Updated: 2012-09-03

Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)

CompletedNCT00239915

Pharmacology Research InstitutePersistent Developmental Stuttering

Start: 2005-04-30End: 2006-12-31Updated: 2012-05-09

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

CompletedNCT00370981

Endo PharmaceuticalsPremature Ejaculation

Start: 2006-07-31End: 2006-10-31Target: 100Updated: 2013-12-27

A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering

CompletedNCT00830154

Endo PharmaceuticalsStuttering

Start: 2009-02-28End: 2011-01-31Updated: 2012-08-28